United States:
MintzEdge 101: FDA For Start-Ups
To print this article, all you need is to be registered or login on Mondaq.com.
In this episode of MintzEdge's From the Edge podcast, Sam
Effron speaks with Ben Zegarelli of Mintz about considerations for
new medical device, pharmaceutical, or other health regulated
start-ups and strategies for how to prepare for FDA oversight.
January 14, 2020
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
Manatt Health: Health AI Policy Tracker
Manatt, Phelps & Phillips LLP
The purpose of this quarterly tracker is to identify key federal and state health AI policy activity. Below reflects federal legislative and regulatory activity to date related to AI...